Development of Pediatric Dosing for Mepolizumab in Severe Asthma Based on Extrapolation of Data From Adult Patients and a Phase II Open-Label Pediatric Trial.
- DOI
- 10.1002/jcph.70155
- Published
- 2026 Feb
- Container
- Journal of clinical pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/jcph.70155,
title = {Development of Pediatric Dosing for Mepolizumab in Severe Asthma Based on Extrapolation of Data From Adult Patients and a Phase II Open-Label Pediatric Trial.},
author = {Gupta A and Pouliquen IJ and Phipatanakul W and Austin D and Whelan G and Price RG and Finney-Hayward T and Derey S and Steinfeld J},
year = {2026},
journal = {Journal of clinical pharmacology},
doi = {10.1002/jcph.70155},
url = {https://doi.org/10.1002/jcph.70155}
}RIS
TY - JOUR TI - Development of Pediatric Dosing for Mepolizumab in Severe Asthma Based on Extrapolation of Data From Adult Patients and a Phase II Open-Label Pediatric Trial. AU - Gupta A AU - Pouliquen IJ AU - Phipatanakul W AU - Austin D AU - Whelan G AU - Price RG AU - Finney-Hayward T AU - Derey S AU - Steinfeld J PY - 2026 JO - Journal of clinical pharmacology DO - 10.1002/jcph.70155 UR - https://doi.org/10.1002/jcph.70155 ER -
APA
A, G., IJ, P., W, P., D, A., G, W., RG, P., T, F., S, D., & J, S. (2026). Development of Pediatric Dosing for Mepolizumab in Severe Asthma Based on Extrapolation of Data From Adult Patients and a Phase II Open-Label Pediatric Trial.. Journal of clinical pharmacology. https://doi.org/10.1002/jcph.70155
Source records
- pubmed · retrieved 2026-09-25T18:00:42.491Z